During liver and breast cancer development, HBXIP reportedly promotes tumor cell proliferation through transcriptional activation of crucial tumor oncogenes, including YAP, SKP2, and Lin28B13,19,21. The gene discussed is SKP2; the disease is breast carcinoma.